Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study

被引:18
作者
Duffett, Mark [1 ,2 ,3 ,4 ]
Chan, Alice [5 ]
Closs, Jordan [1 ]
McGloin, Rumi [6 ,7 ]
McKelvie, Greg [8 ]
Pong, Sandra [9 ]
Seto, Winnie [9 ]
Slaney, Heather [10 ]
Vaninetti, Gina [11 ]
Vanniyasingam, Thuva [12 ]
机构
[1] McMaster Childrens Hosp, Dept Pharm, Hamilton, ON, Canada
[2] McMaster Univ, Dept Pediat & Hlth Res Methods, Hamilton, ON, Canada
[3] McMaster Univ, Dept Evidence, Hamilton, ON, Canada
[4] McMaster Univ, Dept Impact, Hamilton, ON, Canada
[5] Stollery Childrens Hosp, Dept Pharm, Alberta Hlth Serv, Edmonton, AB, Canada
[6] Surrey Mem Hosp, Dept Pharm, Surrey, BC, Canada
[7] Jim Pattison Outpatient Care & Surg Ctr, Surrey, BC, Canada
[8] Victoria Gen Hosp, Dept Pharm, Vancouver Isl Hlth Author, Victoria, BC, Canada
[9] Hosp Sick Children, Dept Pharm, Toronto, ON, Canada
[10] Janeway Childrens Hlth & Rehabil Ctr, Dept Pharm, St John, NF, Canada
[11] IWK Hlth Ctr, Dept Pharm, Halifax, NS, Canada
[12] St Josephs Healthcare, Hamilton, ON, Canada
关键词
cohort studies; gastrointestinal hemorrhage; histamine H2 antagonists; intensive care units; pediatric; proton-pump inhibitors; risk factors; INTENSIVE-CARE-UNIT; RISK-FACTORS;
D O I
10.1097/PCC.0000000000002202
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To describe current stress ulcer prophylaxis practice in Canadian PICUs. Design: Multicenter cohort study. We defined stress ulcer prophylaxis as the use of a proton-pump inhibitor, histamine-2 receptor antagonist, or sucralfate within the first 2 PICU days among children who had not been on these medications at home and had no evidence of gastrointestinal bleeding. Setting: Seven PICUs in Canada. Patients: Three hundred seventy-eight children requiring mechanical ventilation. Interventions: None. Measurements and Main Results: Children were ventilated for a median (interquartile range) of 2 days (1-6 d) and stayed in the PICU for a median (interquartile range) of 4 days (2-10 d). The median (interquartile range) age was 1.3 years (0.3-6.7 yr). Seventy percent of all children received acid suppression during their PICU stay. One hundred sixty-seven (54%) of the 309 children eligible for stress ulcer prophylaxis received it. Histamine-2 receptor antagonists were the most frequently used class (66%), followed by proton-pump inhibitors (47%) and sucralfate (4%), and 20% received more than one class. Stress ulcer prophylaxis was continued on the PICU transfer orders for 34% of these children. Children who received prophylaxis were older and had a higher Pediatric Risk of Mortality III score, more often received nonsteroidal anti-inflammatory drugs and systemic corticosteroids and received less enteral nutrition. In multivariate analysis, age and invasive mechanical ventilation were independently associated with an increased likelihood of receiving stress ulcer prophylaxis and receiving feeds was independently associated with a decreased likelihood of receiving stress ulcer prophylaxis. Gastrointestinal bleeding was reported in 21 (6%) of 378 children; three (0.8%) were clinically important. Eighteen percent were treated for a new respiratory tract infection, and 1% developed Clostridium difficile-associated diarrhea. Conclusions: Stress ulcer prophylaxis is common in Canadian PICUs. Clinically important gastrointestinal bleeding and C. difficile-associated diarrhea are rare, and the utility of routine prophylaxis should be examined.
引用
收藏
页码:E107 / E113
页数:7
相关论文
共 15 条
[1]   Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia [J].
Albert, Ben D. ;
Zurakowski, David ;
Bechard, Lori J. ;
Priebe, Gregory P. ;
Duggan, Christopher P. ;
Heyland, Daren K. ;
Mehta, Nilesh M. .
PEDIATRIC CRITICAL CARE MEDICINE, 2016, 17 (10) :924-929
[2]  
Araujo TE, 2010, J PEDIAT-BRAZIL, V86, P525, DOI [10.2223/JPED.2046, 10.1590/S0021-75572010000600014]
[3]   Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: A prospective study [J].
Chaibou, M ;
Tucci, M ;
Dugas, MA ;
Farrell, CA ;
Proulx, F ;
Lacroix, J .
PEDIATRICS, 1998, 102 (04) :933-938
[4]   Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database [J].
Costarino, Andrew T. ;
Dai, Dingwei ;
Feng, Rui ;
Feudtner, Chris ;
Guevara, James P. .
PEDIATRIC CRITICAL CARE MEDICINE, 2015, 16 (07) :605-612
[5]   Incidence and risk factors of upper gastrointestinal bleeding in mechanically ventilated children [J].
Deerojanawong, Jitladda ;
Peongsujarit, Danayawan ;
Vivaltvakin, Boosba ;
Prapphal, Nuanchan .
PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (01) :91-95
[6]  
Duffett M, 2016, STRESS ULCER PROPHYL
[7]  
Duffett M, 2017, CAN J HOSP PHARM, V70, P288
[8]   Pediatric intensive care stress ulcer prevention (PIC-UP): A protocol for a pilot randomized trial [J].
Duffett M. ;
Choong K. ;
Foster J. ;
Gilfoyle E. ;
Lacroix J. ;
Pai N. ;
Thabane L. ;
Cook D.J. .
Pilot and Feasibility Studies, 3 (1)
[9]   Making Decisions About Medications in Critically Ill Children: A Survey of Canadian Pediatric Critical Care Clinicians [J].
Duffett, Mark ;
Choong, Karen ;
Vanniyasingam, Thuva ;
Thabane, Lehana ;
Cook, Deborah J. .
PEDIATRIC CRITICAL CARE MEDICINE, 2015, 16 (01) :21-28
[10]  
Gauvin F, 2001, Pediatr Crit Care Med, V2, P294, DOI 10.1097/00130478-200110000-00002